These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7670148)

  • 1. Pulmonary toxicity of continuous infusion 5-fluoro-2'-deoxyuridine.
    Chu SI; Kim HJ; Skubitz KM
    Anticancer Drugs; 1995 Jun; 6(3):475-8. PubMed ID: 7670148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases.
    Wong MK; Bjarnason GA; Hrushesky WJ; Webster P; Morava-Protzner I; Towers M
    Cancer; 1995 May; 75(10):2558-64. PubMed ID: 7736401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant chemotherapy].
    Del Nero A; Mandressi A; Longo G; Cogni M; Mangiarotti B; Buzzetti V; Russo R
    Arch Ital Urol Nefrol Androl; 1991 Jun; 63(2):249-51. PubMed ID: 1830673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma.
    Conroy T; Geoffrois L; Guillemin F; Luporsi E; Krakowski I; Spaëth D; Frasie V; Volff D
    Cancer; 1993 Oct; 72(7):2190-7. PubMed ID: 8374877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian-shaped infusions of floxuridine for progressive metastatic renal cell carcinoma.
    Hrushesky WJ; von Roemeling R; Lanning RM; Rabatin JT
    J Clin Oncol; 1990 Sep; 8(9):1504-13. PubMed ID: 2144018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer.
    von Roemeling R; Hrushesky WJ
    J Clin Oncol; 1989 Nov; 7(11):1710-9. PubMed ID: 2530318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian-based infusional FUDR therapy.
    Lanning RM; von Roemeling R; Hrushesky WJ
    Oncol Nurs Forum; 1990; 17(1):49-56. PubMed ID: 2137216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive metastatic renal cell carcinoma controlled by continuous 5-fluoro-2-deoxyuridine infusion.
    von Roemeling R; Rabatin JT; Fraley EE; Hrushesky WJ
    J Urol; 1988 Feb; 139(2):259-62. PubMed ID: 2963142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous non chronomodulated infusion of floxuridine in metastatic renal cell carcinoma (MRCC): report of 17 cases.
    Baiocchi C; Landonio G; Cacioppo C; Calgaro M; Cattaneo D; Ferrari M; Majno M
    Tumori; 1996; 82(3):225-7. PubMed ID: 8693598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian continuous chemotherapy of renal cell carcinoma with an implantable, programmable infusion pump.
    Damascelli B; Marchianò A; Spreafico C; Lutman R; Salvetti M; Bonalumi MG; Mauri M; Garbagnati F; Del Nero A; Comeri G
    Cancer; 1990 Jul; 66(2):237-41. PubMed ID: 2142443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
    Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
    J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non invasive ventilation in the treatment of FUdr-induced lesional pulmonary oedema.
    Conti G; Spadetta G; Rocco M; Antonelli M; Ruscio L; Gionfrida E; Angiuli G
    Minerva Anestesiol; 2000; 66(7-8):561-4. PubMed ID: 10965737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic toxicity associated with hepatic artery infusion HAI of FUdR.
    Taylor HG; Wolf CR; Maitland CG
    Cancer Chemother Pharmacol; 1986; 17(3):292-3. PubMed ID: 2943526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.
    Wilkinson MJ; Frye JW; Small EJ; Venook AP; Carroll PR; Ernest ML; Stagg RJ
    Cancer; 1993 Jun; 71(11):3601-4. PubMed ID: 8490909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion.
    Hohn DC; Rayner AA; Economou JS; Ignoffo RJ; Lewis BJ; Stagg RJ
    Cancer; 1986 Feb; 57(3):465-70. PubMed ID: 2935242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusional floxuridine-based therapy for patients with metastatic renal cell carcinoma.
    Reese DM; Corry M; Small EJ
    Cancer; 2000 Mar; 88(6):1310-6. PubMed ID: 10717611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Continuous sinusoid systemic Fudr infusion in advanced colorectal carcinoma. Preliminary experience].
    Civalleri D; Cavallini M; Tirindelli Danesi D; Decian F; Depaoli M; Balletto N
    Minerva Chir; 1992 May; 47(9):853-8. PubMed ID: 1535695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian-based infusional chrono-chemotherapy controls progressive metastatic renal cell carcinoma.
    Hrushesky WJ; Von Roemeling R; Fraley EE; Rabatin JT
    Semin Surg Oncol; 1988; 4(2):110-5. PubMed ID: 2969133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexibility and efficacy of automatic continuous fluorodeoxyuridine infusion in metastases from a renal cell carcinoma.
    Damascelli B; Marchianò A; Frigerio LF; Salvetti M; Spreafico C; Garbagnati F; Zanoni F; Radice F
    Cancer; 1991 Sep; 68(5):995-8. PubMed ID: 1833043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC; Stagg RJ; Friedman MA; Hannigan JF; Rayner A; Ignoffo RJ; Acord P; Lewis BJ
    J Clin Oncol; 1989 Nov; 7(11):1646-54. PubMed ID: 2530317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.